Position in GTBP
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$9,547
New position
Shares Held
23,400
first reported quarter
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invst, LLC holds $1,765,143 across 8 Biotechnology names. GTBP ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
35,205 | $829,429 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,998 | $337,701 | |
| 3 | INCY |
Incyte Corp
|
3,447 | $324,431 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
16,000 | $84,640 | |
| 5 | HURA |
TuHURA Biosciences, Inc./NV
|
42,506 | $76,085 | |
| 6 | CRDF |
Cardiff Oncology, Inc.
|
40,500 | $65,610 | |
| 7 | MRKR |
Marker Therapeutics, Inc.
|
29,000 | $37,700 | |
| 8 | GTBP |
GT Biopharma, Inc.
This page
|
23,400 | $9,547 |
All Filings in GTBP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,547 | 23,400 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||